Drug Shortage Report for FLOLAN
| Report ID | 220338 |
| Drug Identification Number | 02230848 |
| Brand name | FLOLAN |
| Common or Proper name | Epoprostenol Powder for Injection |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | EPOPROSTENOL |
| Strength(s) | 1.5MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1s |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-02-21 |
| Estimated end date | 2024-05-03 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-17 |
| Company comments | For emergency supply, contact GSK Customer Service at 1-800-387-7374 or cacsu@gsk.com. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-04-17 | French | Compare |
| v3 | 2024-04-17 | English | Compare |
| v2 | 2024-02-23 | French | Compare |
| v1 | 2024-02-23 | English | Compare |
Showing 1 to 4 of 4